Linked Data API

Show Search Form

Search Results

1126877
star this property registered interest false more like this
unstar this property date less than 2019-05-15more like thismore than 2019-05-15
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Cybercrime more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how much the National Health Service spent on cyber security in each of the last five years. more like this
star this property tabling member constituency Windsor more like this
star this property tabling member printed
Adam Afriyie more like this
star this property uin 254785 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-05-24more like thismore than 2019-05-24
star this property answer text <p>The information requested on cyber spending covers sensitive detail about cyber security investment for the National Health Service. In this instance, releasing this information at the level of any annual breakdown may assist in determining the effectiveness of detecting cyber-attacks on the NHS, and could compromise measures to protect NHS IT systems, leaving them vulnerable to future cyber-attacks.</p><p>However, in total, over £250 million will have been invested nationally to improve the cyber security of the health and care system between 2016 and 2021. This excludes both investment by local organisations, and wider national IT investment which supports better security such as Microsoft licensing for NHS organisations.</p><p>Regarding the steps taken to defend against cyber attacks on the NHS, the active cyber defence of NHS organisations is a local responsibility for each organisation to carry out. However, there is national support and practical guidance available to NHS organisations which is primarily delivered by NHS Digital but supported and prioritised for the highest risk organisations by NHS England and the Department. In the event of national-scale incidents that affect many health and care organisations, NHS Digital plays a vital role in coordinating and ensuring appropriate technical remediation, as part of the wider cross-system cyber security response led by the Department.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property grouped question UIN 254786 more like this
star this property question first answered
less than 2019-05-24T12:33:05.65Zmore like thismore than 2019-05-24T12:33:05.65Z
star this property answering member
4065
unstar this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
1586
unstar this property label Biography information for Adam Afriyie more like this
1126878
star this property registered interest false more like this
unstar this property date less than 2019-05-15more like thismore than 2019-05-15
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Cybercrime more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure that NHS England is prepared to defend the NHS against cyber attacks. more like this
star this property tabling member constituency Windsor more like this
star this property tabling member printed
Adam Afriyie more like this
star this property uin 254786 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-05-24more like thismore than 2019-05-24
star this property answer text <p>The information requested on cyber spending covers sensitive detail about cyber security investment for the National Health Service. In this instance, releasing this information at the level of any annual breakdown may assist in determining the effectiveness of detecting cyber-attacks on the NHS, and could compromise measures to protect NHS IT systems, leaving them vulnerable to future cyber-attacks.</p><p>However, in total, over £250 million will have been invested nationally to improve the cyber security of the health and care system between 2016 and 2021. This excludes both investment by local organisations, and wider national IT investment which supports better security such as Microsoft licensing for NHS organisations.</p><p>Regarding the steps taken to defend against cyber attacks on the NHS, the active cyber defence of NHS organisations is a local responsibility for each organisation to carry out. However, there is national support and practical guidance available to NHS organisations which is primarily delivered by NHS Digital but supported and prioritised for the highest risk organisations by NHS England and the Department. In the event of national-scale incidents that affect many health and care organisations, NHS Digital plays a vital role in coordinating and ensuring appropriate technical remediation, as part of the wider cross-system cyber security response led by the Department.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property grouped question UIN 254785 more like this
star this property question first answered
less than 2019-05-24T12:33:05.713Zmore like thismore than 2019-05-24T12:33:05.713Z
star this property answering member
4065
unstar this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
1586
unstar this property label Biography information for Adam Afriyie more like this
1141362
star this property registered interest false more like this
unstar this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Measles more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what guidance his Department has published on distinguishing between rashes caused by the measles vaccine and those arising from the wild strain of measles. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 280995 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>While post vaccine rash and fever is generally mild, distinguishing from wild-type measles is not based on clinical examination, rather it is based on a combination of laboratory analysis, information on the timing of vaccine and epidemiological information. The national measles guidelines describe the management and investigation of suspected cases of measles, and is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-measles-guidelines" target="_blank">https://www.gov.uk/government/publications/national-measles-guidelines</a></p><p>Statistics on confirmed measles cases are reported by vaccination status and are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019</a></p><p> </p><p> </p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 280996 more like this
star this property question first answered
less than 2019-08-05T11:32:33.127Zmore like thismore than 2019-08-05T11:32:33.127Z
star this property answering member
4380
unstar this property label Biography information for Jo Churchill more like this
star this property tabling member
1522
unstar this property label Biography information for Adam Holloway more like this
1141363
star this property registered interest false more like this
unstar this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Measles more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that statistics on the infection rate for measles do not include people who have received the live measles vaccine and contracted a measles-like rash and fever. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 280996 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>While post vaccine rash and fever is generally mild, distinguishing from wild-type measles is not based on clinical examination, rather it is based on a combination of laboratory analysis, information on the timing of vaccine and epidemiological information. The national measles guidelines describe the management and investigation of suspected cases of measles, and is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-measles-guidelines" target="_blank">https://www.gov.uk/government/publications/national-measles-guidelines</a></p><p>Statistics on confirmed measles cases are reported by vaccination status and are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019</a></p><p> </p><p> </p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 280995 more like this
star this property question first answered
less than 2019-08-05T11:32:33.183Zmore like thismore than 2019-08-05T11:32:33.183Z
star this property answering member
4380
unstar this property label Biography information for Jo Churchill more like this
star this property tabling member
1522
unstar this property label Biography information for Adam Holloway more like this
1141364
star this property registered interest false more like this
unstar this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading MMR Vaccine: Side Effects more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) body inclusion encephalitis and (b) other adverse events experienced after a measles vaccine are identified in a timely way by healthcare professionals. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 280997 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The safety of all the United Kingdom’s vaccination programmes is of paramount importance. Any serious side effects are extremely rare, and the large majority of side effects are mild and transient, such as sore arms, headaches and tiredness. We would recommend that all eligible children are vaccinated, as any potential risk of side effects is far outweighed by the benefits of vaccination.</p><p>Healthcare professionals have access to a range of materials, such as ‘Immunisation against infectious disease: the green book’ and Patient Group Directions to support their decision-making in the case of any suspected adverse effects.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) operates the ‘Yellow Card Scheme’, which is vital in helping the MHRA monitor the safety of all healthcare products in the UK. This system allows for reporting of any potential adverse events for all medicines, including vaccines, with guidance for healthcare professionals, patients and the public on how to use the scheme.</p><p>In addition, Public Health England (PHE) offers diagnostic services for suspected cases of encephalitis, which is a notifiable condition. Under statutory duty, cases must be reported by healthcare professionals to PHE’s local Health Protection Teams. This can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids" target="_blank">https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids</a></p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-05T11:34:01.177Zmore like thismore than 2019-08-05T11:34:01.177Z
star this property answering member
4380
unstar this property label Biography information for Jo Churchill more like this
star this property tabling member
1522
unstar this property label Biography information for Adam Holloway more like this
1141380
star this property registered interest false more like this
unstar this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading MMR Vaccine: Safety more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to maintain and improve pharmacovigilance in relation to the MMR vaccine. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 280998 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>As with all vaccines and medicines, the safety of the Measles, Mumps and Rubella (MMR) vaccine remains under continual review by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA uses all available sources of evidence in pharmacovigilance, including regular review of suspected adverse reactions submitted through the Yellow Card Scheme, data from clinical and epidemiological studies, the medical literature and information from pharmaceutical companies and other worldwide regulatory authorities. The MHRA’s processes and data analysis systems are regularly evaluated to ensure optimal performance in monitoring the safety of vaccines and medicines.</p><p>The balance of benefits and risks of MMR vaccine remains overwhelmingly favourable.</p> more like this
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2019-07-25T16:35:38.84Zmore like thismore than 2019-07-25T16:35:38.84Z
star this property answering member
4065
unstar this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
1522
unstar this property label Biography information for Adam Holloway more like this
1141381
star this property registered interest false more like this
unstar this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading MMR Vaccine more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure (a) transparency and (b) accountability in the process of manufacturing the MMR vaccine. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 280999 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>Two Measles, Mumps and Rubella (MMR) vaccines are licensed for use in the United Kingdom: M-M-RVaxPro and Priorix. Both vaccines are on the National Health Service’s routine immunisation schedule. The quality, safety and efficacy of both M-M-RVaxPro and Priorix have been evaluated before they were given a Marketing Authorisation in Europe, and the Marketing Authorisation Holder for each vaccines is legally required to submit periodic safety update reports to the regulator, which are documents intended to provide an evaluation of the risk-benefit balance of a medicinal product at defined time points after its authorisation. The sites at which the products are manufactured are also required to undergo periodic inspections to ensure that they comply with Good Manufacturing Practices. Each batch of vaccines is tested by an official medicines control laboratory (OMCL). OMCL testing is independent of and in addition to the manufacturer’s testing. These procedures ensure that the MMR vaccines available in the UK are safe and efficacious and that the manufacturers/Marketing Authorisation holders are held accountable for their products.</p><p>A European Public Assessment Report (EPAR) for M-M-RVaxPro is available at the following link:</p><p><a href="https://www.ema.europa.eu/en/documents/scientific-discussion/m-m-rvaxpro-epar-scientific-discussion_en.pdf" target="_blank">https://www.ema.europa.eu/en/documents/scientific-discussion/m-m-rvaxpro-epar-scientific-discussion_en.pdf</a></p><p>Priorix was approved before public assessment reports were a requirement. The EPAR for M-M-RVaxPro contains a general summary of the manufacturing information that was provided during the assessment process; however, the specific details of the manufacturing process are confidential.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2019-07-25T16:38:57.347Zmore like thismore than 2019-07-25T16:38:57.347Z
star this property answering member
4065
unstar this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
1522
unstar this property label Biography information for Adam Holloway more like this
1141825
star this property registered interest false more like this
unstar this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading MMR Vaccine more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that parents and carers are provided with accurate information on the benefits and risks of the MMR vaccine. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 281668 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-09-09more like thismore than 2019-09-09
star this property answer text <p>The National Health Service website has a dedicated page on the measles, mumps and rubella (MMR) vaccine, which can be found at the following link:</p><p><a href="https://www.nhs.uk/conditions/vaccinations/mmr-vaccine/" target="_blank">https://www.nhs.uk/conditions/vaccinations/mmr-vaccine/</a></p><p>In addition, Public Health England provides information on the benefits and risks of the MMR vaccine to the public using NHS branded leaflets, some of which are available in multiple languages. The leaflets address common questions about the MMR vaccine. In addition to parents and carers this information is designed for use by schools, healthcare centres, accident and emergency departments, hospital wards, walk-in centres and general practices.</p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-09-09T14:56:52.257Zmore like thismore than 2019-09-09T14:56:52.257Z
star this property answering member
4380
unstar this property label Biography information for Jo Churchill more like this
star this property tabling member
1522
unstar this property label Biography information for Adam Holloway more like this
1167115
star this property registered interest false more like this
unstar this property date less than 2019-10-29more like thismore than 2019-10-29
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Diagnosis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the Written Statement of 16 September 2019, Official Report, HCWS11, when Professor Sir Mike Richards plans to publish his follow-up report on diagnostic capacity. more like this
star this property tabling member constituency Manchester, Gorton more like this
star this property tabling member printed
Afzal Khan more like this
star this property uin 7219 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-11-05more like thismore than 2019-11-05
star this property answer text <p>As outlined in the published Terms of Reference for Professor Sir Mike Richards’ review of national adult screening programmes, the follow-up report on diagnostic capacity will be published by the end of the year. A copy of the related Terms of Reference can be found at the following link:</p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/02/review-of-national-cancer-screening-programmes-tor-20191016.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/02/review-of-national-cancer-screening-programmes-tor-20191016.pdf</a></p><p> </p><p><strong> </strong></p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-11-05T10:34:40.98Zmore like thismore than 2019-11-05T10:34:40.98Z
star this property answering member
4380
unstar this property label Biography information for Jo Churchill more like this
star this property tabling member
4671
unstar this property label Biography information for Afzal Khan more like this
1167116
star this property registered interest false more like this
unstar this property date less than 2019-10-29more like thismore than 2019-10-29
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Breast Cancer: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to his Written Statement of 16 September 2019, Official Report, HCWS11, what the timeframe is for NHSX to complete its delivery of new IT systems to support the breast screening programme. more like this
star this property tabling member constituency Manchester, Gorton more like this
star this property tabling member printed
Afzal Khan more like this
star this property uin 7220 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-11-05more like thismore than 2019-11-05
star this property answer text <p>NHSX, Public Health England, NHS Digital, NHS England and NHS Improvement have established a programme to modernise the IT systems on which the national screening programmes are delivered. The programme is applying the Government Digital Service’s ‘agile’ approach and has recently commenced a prototyping ('alpha') phase focussed on the “call and recall” of screening participants. The alpha will end in January 2020, at which point it will be clearer what is required and the likely timescales.</p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-11-05T10:36:40.13Zmore like thismore than 2019-11-05T10:36:40.13Z
star this property answering member
4380
unstar this property label Biography information for Jo Churchill more like this
star this property tabling member
4671
unstar this property label Biography information for Afzal Khan more like this